Capital Research Global Investors 13D and 13G filings for Integra LifeSciences Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 12:54 pm Sale | 2024-11-07 | 13G | Integra LifeSciences Holdings Corporation IART | Capital Research Global Investors | 1,304,615 1.700% | -2,992,711 (-69.64%) | Filing |
| 2024-02-09 5:49 pm Purchase | 2024-02-07 | 13G | Integra LifeSciences Holdings Corporation IART | Capital Research Global Investors | 4,297,326 5.500% | 427,556 (+11.05%) | Filing |
| 2022-07-08 11:22 am Sale | 2022-07-08 | 13G | Integra LifeSciences Holdings Corporation IART | Capital Research Global Investors | 3,869,770 4.700% | -4,349,363 (-52.92%) | Filing |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Integra LifeSciences Holdings Corporation IART | Capital Research Global Investors | 8,219,133 9.700% | -18,148 (-0.22%) | Filing |
| 2021-02-16 3:11 pm Sale | 2021-02-16 | 13G | Integra LifeSciences Holdings Corporation IART | Capital Research Global Investors | 8,237,281 9.800% | -883,672 (-9.69%) | Filing |
| 2020-02-14 12:03 pm Sale | 2019-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | Capital Research Global Investors | 9,120,953 10.600% | -519,590 (-5.39%) | Filing |